International Journal of Preclinical and Clinical Research
Year: 2021, Volume: 2, Issue: 1, Pages: 28-30
Case Report
T S Rajesh1*, A N Pallavi2
1 Assistant professor, Department of Neurosurgery, Mysore Medical College and Research Institute, Mysore, Karnataka, India
2 Junior Resident, Department of Surgery, Mysore Medical College and Research Institute, Mysore, Karnataka, India
*Corresponding author
Email: [email protected]
Received Date:28 December 2020, Accepted Date:07 April 2021, Published Date:10 April 2021
Reporting a rare case of Calvarial Cavernous Hemangioma. A 2-months-oldmale baby presented with Right Frontal swelling noticed when baby was 20days old rapidly progressive in size. On examination, it was solitary 6*7cm firm irregular swelling fixed to bone which On CT/MRI showed 6*5*4cm mixed density extra axial lesion in right frontal region with bony destruction causing mass effect and mid line shift? neoplastic. Baby had no neurological deficits. CBC showed Pancytopenia. Patient was operated under GA, total excision of the lesion and margin of surrounding eroded bone was performed. Tumor was completely extradural. Histopathology showed Bony trabeculae separated by loose fibrocollagenous tissue enclosing many endothelium lined Vascular spaces. Post operative no recurrence is observed. Cavernous Hemangioma of skull is very rare in infancy and must be included in differential diagnosis of skull lesions . Untreated Cavernous Hemangiomas may show progression. A suspected Neoplastic swelling turned out to be benign lesion. Timely operative intervention prevented complications due to severe anemia because of intralesional bleed.
Keywords: Calvaria; Cavernous Hemangioma; Benign
© 2021 Rajesh & Pallavi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Published By Basaveshwara Medical College & Hospital, Chitradurga, Karnataka.
Subscribe now for latest articles and news.